Hologic - The Healthcare Company Benefits from Rising Treatment Numbers!
Reading Time: 1 minute
Business drivers: Hologic (HOLX) has made a name for itself in diagnostics and medical imaging and is considered one of the leading players in advanced laboratory and medical technology. With innovative methods such as digital breast tomosynthesis (DBT), also known as 3D mammography, and NovaSure, a minimally invasive technique for endometrial ablation, they are well-positioned in the field of women's health. On September 19, Argus Research confirmed their rating as Buy and raised the price target from $80 to $90.
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
